These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32995795)

  • 21. Comorbidities and Susceptibility to COVID-19: A Generalized Gene Set Data Mining Approach.
    Beckman MF; Mougeot FB; Mougeot JC
    J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33924631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Host Factor Interaction Networks Identified by Integrative Bioinformatics Analysis Reveals Therapeutic Implications in COPD Patients With COVID-19.
    Zheng W; Wang T; Wu P; Yan Q; Liu C; Wu H; Zhan S; Liu X; Jiang Y; Zhuang H
    Front Pharmacol; 2021; 12():718874. PubMed ID: 35002688
    [No Abstract]   [Full Text] [Related]  

  • 23. Predicting COVID-19-Comorbidity Pathway Crosstalk-Based Targets and Drugs: Towards Personalized COVID-19 Management.
    Barh D; Aljabali AA; Tambuwala MM; Tiwari S; Serrano-Aroca Á; Alzahrani KJ; Silva Andrade B; Azevedo V; Ganguly NK; Lundstrom K
    Biomedicines; 2021 May; 9(5):. PubMed ID: 34067609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients under investigation for COVID-19: Where is the first point that the patients are recruited?
    Yasri S; Wiwanitkit V
    J Res Med Sci; 2020; 25():102. PubMed ID: 33824667
    [No Abstract]   [Full Text] [Related]  

  • 25. Functional Landscape of SARS-CoV-2 Cellular Restriction.
    Martin-Sancho L; Lewinski MK; Pache L; Stoneham CA; Yin X; Pratt D; Churas C; Rosenthal SB; Liu S; De Jesus PD; O'Neill AM; Gounder AP; Nguyen C; Pu Y; Oom AL; Miorin L; Rodriguez-Frandsen A; Urbanowski M; Shaw ML; Chang MW; Benner C; Frieman MB; García-Sastre A; Ideker T; Hultquist JF; Guatelli J; Chanda SK
    bioRxiv; 2020 Sep; ():. PubMed ID: 33024967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A potent SARS-CoV-2 neutralizing human monoclonal antibody that reduces viral burden and disease severity in Syrian hamsters.
    Fagre AC; Manhard J; Adams R; Eckley M; Zhan S; Lewis J; Rocha SM; Woods C; Kuo K; Liao W; Li L; Corper A; Challa D; Mount E; Tumanut C; Tjalkens RB; Aboelleil T; Fan X; Schountz T
    bioRxiv; 2020 Sep; ():. PubMed ID: 33024962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence of a wide gap between COVID-19 in humans and animal models: a systematic review.
    Ehaideb SN; Abdullah ML; Abuyassin B; Bouchama A
    Crit Care; 2020 Oct; 24(1):594. PubMed ID: 33023604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-10 served as an indicator in severe COVID-19 patients.
    Huang F; Liu X; Sun X; Li Z
    J Med Virol; 2021 Mar; 93(3):1233-1235. PubMed ID: 33022800
    [No Abstract]   [Full Text] [Related]  

  • 29. The determinants of COVID-19 case fatality rate (CFR) in the Italian regions and provinces: An analysis of environmental, demographic, and healthcare factors.
    Perone G
    Sci Total Environ; 2021 Feb; 755(Pt 1):142523. PubMed ID: 33022464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 and myeloid cells: complex interplay correlates with lung severity.
    D'Alessio FR; Heller NM
    J Clin Invest; 2020 Dec; 130(12):6214-6217. PubMed ID: 33021506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control of systemic inflammation through early nitric oxide supplementation with nitric oxide releasing nanoparticles.
    Williams AT; Muller CR; Govender K; Navati MS; Friedman AJ; Friedman JM; Cabrales P
    Free Radic Biol Med; 2020 Dec; 161():15-22. PubMed ID: 33011274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-Based Therapy for Severe COVID-19 Patients: Clinical Trials and Cost-Utility.
    Golchin A
    Stem Cell Rev Rep; 2021 Feb; 17(1):56-62. PubMed ID: 33009982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arenaria kansuensis attenuates pulmonary fibrosis in mice via the activation of Nrf2 pathway and the inhibition of NF-kB/TGF-beta1/Smad2/3 pathway.
    Cui Y; Xin H; Tao Y; Mei L; Wang Z
    Phytother Res; 2021 Feb; 35(2):974-986. PubMed ID: 32996197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reinfection with SARS-CoV-2 and Failure of Humoral Immunity: a case report.
    Goldman JD; Wang K; Röltgen K; Nielsen SCA; Roach JC; Naccache SN; Yang F; Wirz OF; Yost KE; Lee JY; Chun K; Wrin T; Petropoulos CJ; Lee I; Fallen S; Manner PM; Wallick JA; Algren HA; Murray KM; Su Y; Hadlock J; Jeharajah J; Berrington WR; Pappas GP; Nyatsatsang ST; Greninger AL; Satpathy AT; Pauk JS; Boyd SD; Heath JR
    medRxiv; 2020 Sep; ():. PubMed ID: 32995830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deep Immune Profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19.
    Vella L; Giles JR; Baxter AE; Oldridge DA; Diorio C; Kuri-Cervantes L; Alanio C; Pampena MB; Wu JE; Chen Z; Huang YJ; Anderson EM; Gouma S; McNerney KO; Chase J; Burudpakdee C; Lee JH; Apostolidis SA; Huang AC; Mathew D; Kuthuru O; Goodwin EC; Weirick ME; Bolton MJ; Arevalo CP; Ramos A; Jasen C; Giannini HM; DAndrea K; Meyer NJ; Behrens EM; Bassiri H; Hensley SE; Henrickson SE; Teachey DT; Betts MR; Wherry EJ
    medRxiv; 2020 Oct; ():. PubMed ID: 32995826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of COVID-19 comorbidities reveals genes and pathways coincident with the SARS-CoV-2 viral disease.
    Dolan ME; Hill DP; Mukherjee G; McAndrews MS; Chesler EJ; Blake JA
    bioRxiv; 2020 Sep; ():. PubMed ID: 32995795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of COVID-19 comorbidities reveals genes and pathways coincident with the SARS-CoV-2 viral disease.
    Dolan ME; Hill DP; Mukherjee G; McAndrews MS; Chesler EJ; Blake JA
    Sci Rep; 2020 Nov; 10(1):20848. PubMed ID: 33257774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptomic analysis reveals novel mechanisms of SARS-CoV-2 infection in human lung cells.
    Yang S; Wu S; Yu Z; Huang J; Zhong X; Liu X; Zhu H; Xiao L; Deng Q; Sun W
    Immun Inflamm Dis; 2020 Dec; 8(4):753-762. PubMed ID: 33124193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities.
    Arisan ED; Dart A; Grant GH; Arisan S; Cuhadaroglu S; Lange S; Uysal-Onganer P
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32512929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity?
    Bassendine MF; Bridge SH; McCaughan GW; Gorrell MD
    J Diabetes; 2020 Sep; 12(9):649-658. PubMed ID: 32394639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.